Sustained maternal human immunodeficiency virus viral load suppression and cascade of human immunodeficiency virus testing among exposed infants in Rwanda

Table 4 Maternal and facility characteristics associated with persistent human immunodeficiency virus testing among human immunodeficiency virus exposed infants in Rwanda

Characteristics	Bivariate		Multivariable
	RR (95%CI)	P value	Adjusted RR (95%CI)	P value
Age
18-24	Reference
25-34	1.03 (0.95–1.13)	0.376
35-50	1.04 (0.95–1.13)	0.406
Marital status
Single	Reference
Married or living together	1.02 (0.96–1.08)	0.470
Divorced/widowed	0.97 (0.87–1.08)	0.568
Assigned to peer educator
No	Reference		Reference
Yes	1.05 (1.01–1.10)	0.0231	1.06 (1.01–1.11)	0.0211
Human immunodeficiency virus status disclosed
No	Reference		Reference
Yes	0.96 (0.92–1.01)	0.120	0.97 (0.92–1.02)	0.184
Prior exposure to ART
No	Reference
Yes	0.99 (0.95–1.04)	0.651
Pregnant at the start of ART
No	Reference		Reference
Yes	0.96 (0.92–1.01)	0.103	0.97 (0.93–1.02)	0.225
Number of pregnancies since start
0	Reference
1-2	1.01 (0.95–1.08)	0.747
≥ 3	0.97 (0.88–1.06)	0.507
Place of delivery
Hospital	Reference
Home	0.92 (0.77–1.12)	0.413
Type of health care facility
Clinic	Reference
Health center	1.11 (0.88–1.40)	0.393
Number of health care workers
1-5	Reference		Reference
6-10	0.98 (0.93–1.03)	0.463	0.99 (0.94–1.03)	0.571
≥ 11	1.04 (0.98–1.10)	0.154	1.06 (0.99–1.13)	0.091

¹Indicates significant P value.

ART: Anti-retroviral therapy; RR: Risk ratio; Ref: Reference.